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Photoreceptor death is the endpoint of many blind-
ing diseases. Identifying unifying pathogenic mecha-
nisms in these diseasesmay offer global approaches
for facilitating photoreceptor survival. We found
that rod or cone photoreceptor-specific deletion
of nicotinamide phosphoribosyltransferase (Nampt),
the rate-limiting enzyme in the major NAD+ biosyn-
thetic pathway beginning with nicotinamide, caused
retinal degeneration. In both cases, we could rescue
vision with nicotinamide mononucleotide (NMN).
Significantly, retinal NAD+ deficiency was an early
feature of multiple mouse models of retinal dysfunc-
tion, including light-induced degeneration, strepto-
zotocin-induced diabetic retinopathy, and age-asso-
ciated dysfunction. Mechanistically, NAD+ deficiency
caused metabolic dysfunction and consequent
photoreceptor death. We further demonstrate that
the NAD+-dependent mitochondrial deacylases
SIRT3 and SIRT5 play important roles in retinal ho-
meostasis and that NAD+ deficiency causes SIRT3
dysfunction. These findings demonstrate that NAD+
biosynthesis is essential for vision, provide a founda-
tion for future work to further clarify the mechanisms
involved, and identify a unifying therapeutic target
for diverse blinding diseases.INTRODUCTION
Vision is a crucial sense that depends on photoreceptors for light
transduction. Photoreceptors are divided into two classes: rods
and cones. Rod photoreceptors mediate dim vision, while cone
photoreceptors mediate precise central vision in ambient light.
Photoreceptors make up a significant portion of the neurosen-Cel
This is an open access article undsory retina, one of the most metabolically active tissues in the
body (Ames et al., 1992; Kooragayala et al., 2015; Okawa
et al., 2008). Although terminally differentiated and non-prolifer-
ative, photoreceptors have tremendous metabolic demands
throughout their lives and experience significant light-induced
oxidative stress due to their function of performing light trans-
duction (Fu and Yau, 2007; Yau and Hardie, 2009).
Because of the critical role that photoreceptors play in light
transduction, photoreceptor death leads to blindness. Despite
their differing etiologies, many blinding diseases share this final
pathway of photoreceptor death, which inevitably causes vision
loss. For example, age-related macular degeneration (AMD)
is a leading cause of blindness in older adults (Apte, 2010; Klein
et al., 2004; van Leeuwen et al., 2003). Although advanced AMD
takes on two forms (i.e., dry or wet AMD) (Sene and Apte, 2014),
both pathways ultimately lead to photoreceptor death. Similarly,
inherited retinal degenerations, including retinitis pigmentosa
(RP), rod and cone dystrophies, and Leber congenital amaurosis
(LCA), are caused by genetic defects in over 100 different genes
that lead to photoreceptor death (Astuti et al., 2016; Hartong
et al., 2006; Wright et al., 2010). Developing treatment strategies
for this broad spectrum of retinal degenerative diseases is
challenging given these diverse pathogenic mechanisms.
Nicotinamide adenine dinucleotide (NAD+) is both an essen-
tial coenzyme, functioning as an electron carrier in glycol-
ysis and the Krebs cycle, and an essential cosubstrate for
NAD+-consuming enzymes, including sirtuins, poly(ADP-ribose)
polymerases (PARPs), mono-ADP ribosyltransferases, and cy-
clic ADP-ribose hydrolase (CD38) (Ying, 2006). Given these
numerous functions, NAD+ has been shown to be important
in many biological processes, including metabolism (Garten
et al., 2009; Mouchiroud et al., 2013), circadian rhythms (Naka-
hata et al., 2009; Ramsey et al., 2009), and aging (Imai and Guar-
ente, 2014). Relevant to our studies, NAD+ has also been shown
to be important in neurodegeneration (Alano et al., 2010; Gerdts
et al., 2015; Stein et al., 2014; Zhou et al., 2015). However, the
role of NAD+ in retinal degeneration has been relatively unex-
plored to date.l Reports 17, 69–85, September 27, 2016 ª 2016 The Author(s). 69
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
We hypothesized that NAD+ biosynthesis plays an important
role in photoreceptor function and survival. This hypothesis is
supported by past studies demonstrating that LCA, the leading
cause of childhood blindness from retinal disease, can be
caused by mutations in nicotinamide mononucleotide adenylyl-
transferase 1 (NMNAT1) (Chiang et al., 2012; Falk et al., 2012;
Koenekoop et al., 2012; Perrault et al., 2012), an enzyme
involved in NAD+ biosynthesis. The various mutant forms of
NMNAT1 associated with LCA exhibit reduced NAD+ biosyn-
thetic capacity and/or impaired protein folding (Falk et al.,
2012; Koenekoop et al., 2012; Sasaki et al., 2015), with both fac-
tors contributing to disease pathogenesis.
NAD+ can be synthesized in three ways: (1) de novo from tryp-
tophan, (2) salvaged from nicotinamide or nicotinic acid (NAM or
NA, respectively), or (3) from nicotinamide riboside (NR). Inmam-
mals, the salvage pathway beginning with NAM is the predomi-
nant NAD+ biosynthetic pathway (Imai and Yoshino, 2013; Imai
and Guarente, 2014). The first step of this biosynthetic
pathway is catalyzed by nicotinamide phosphoribosyltransfer-
ase (NAMPT), which combines NAM with 5-phosphoribosyl py-
rophosphate (PRPP) to form nicotinamide mononucleotide
(NMN). NMN is then adenylated by NMNAT1-3 to synthesize
NAD+.
In this study, we focus on the role of NAMPT-mediated NAD+
biosynthesis in photoreceptor survival and vision. Our results
suggest that NAD+ biosynthesis may be important not only in
LCA but also in a broad spectrum of retinal degenerations and
age-associated retinal dysfunction, opening up the possibility
of using NAD+ intermediates to protect against retinal degener-
ation. Although these studies provide a strong foundation for
future studies in this area, further work is needed to clarify the
mechanisms involved. If successful, this therapeutic strategy
would be far-reaching, since it could be used for diverse retinal
degenerations regardless of their etiology.
RESULTS
Loss of NAMPT-Mediated NAD+ Biosynthesis Impairs
Photoreceptor Survival and Vision
Photoreceptors are one of the most metabolically active cells of
the body, with demanding energy requirements (Ames et al.,
1992; Okawa et al., 2008) but limited mitochondrial reserve
capacity (Kooragayala et al., 2015). Therefore, we hypothe-
sized that photoreceptors depend on NAMPT-mediated NAD+
biosynthesis to meet their catalytic requirements. To test this
hypothesis, we examined the effect of disrupting NAMPT-
mediated NAD+ biosynthesis, the predominant pathway in
mammals, selectively in rod photoreceptors by generating con-
ditional knockout mice lacking Nampt in rod photoreceptors
(Namptrod/rod).
As expected, rod-enriched retinal isolates from
Namptrod/rod mice showed significant reduction in Nampt
gene expression (Figure 1A). This rod photoreceptor-specific
deletion ofNampt led to a26% reduction in retinal NAD+ levels
in Namptrod/rod mice compared to NamptF/F littermates at
3 weeks (Figure 1B). We also measured NAD+ levels in rod-en-
riched retinal isolates to more specifically characterize the
magnitude of NAD+ deficiency in rod photoreceptors. We found70 Cell Reports 17, 69–85, September 27, 2016that rod-enriched isolates from Namptrod/rod mice had a
43% reduction in NAD+ levels compared to those from
NamptF/F mice (Figure 1C), suggesting that the NAD+ deficiency
is predominantly specific to the rod photoreceptors.
On biomicroscopy, we found that Namptrod/rod mice
had a degenerative phenotype that, by 6 weeks, was char-
acterized by massive atrophy of the neurosensory retina,
vascular attenuation with pigment mottling, and atrophy of
the underlying retinal pigment epithelium (RPE) cells, which
was not observed in NamptF/F littermates (Figure 1D). This
neurosensory retinal degeneration was also associated with
secondary atrophy and pallor of the optic nerve (Figure 1D).
We confirmed this degeneration with histological examination
of eyes from Namptrod/rod mice. Although the histology
was relatively normal at 2 weeks (Figure S1A), there was
progressive loss of the outer nuclear layer with associated
retinal degeneration, significant reduction of retinal thick-
ness, and secondary extension to multiple retinal layers in
Namptrod/rod eyes that was complete by 6 weeks (Figure 1E).
Of note, the outer nuclear layer (arrows; Figure 1E) appeared
to be almost completely absent by 6 weeks, indicating sub-
stantial photoreceptor death.
We performed electroretinography (ERG) to confirm the
functional deficits associated with this profound anatomic
degeneration. By 6 weeks, Namptrod/rod mice demonstrated
a dramatic reduction in the amplitudes of rod-generated
scotopic a-waves (Figure 1F), indicating significant impair-
ment of rod function. This impairment in rod photoreceptor
function also led to declines in the amplitudes of the scotopic
b-waves (Figure 1G). Interestingly, Namptrod/rod mice also
exhibited deficits in cone function, as manifested by a decline
in the amplitudes of the photopic b-waves (Figure 1H).
Although Nampt deletion was specifically in rods, this cone
dysfunction was not surprising; cone photoreceptor degenera-
tion is often observed as a secondary effect of rod photore-
ceptor degeneration, since rods are required for cone survival
(Aı¨t-Ali et al., 2015; Wong and Kwok, 2016). Consistently, by
6 weeks, Namptrod/rod mice had significantly worse photopic
visual acuity compared to age-matched NamptF/F controls
(Figure 1I). As such, our findings replicate the progression
of rod degeneration followed by cone degeneration that is
often observed in patients with inherited retinal degenerations
such as RP.
We also generated Namptrod/wt mice to determine the effect
of partial ablation of NAMPT-mediated NAD+ biosynthesis. As
expected, rod-enriched retinal isolates from Namptrod/wt mice
exhibited partial reduction in Nampt expression compared to
NamptF/wt controls (Figure S1B), which was roughly half of the
reduction in Namptrod/rod versus NamptF/F mice. This single-
allele Nampt deletion did not cause a statistically significant
reduction in retinal NAD+ levels (Figure S1C), nor did it cause sig-
nificant retinal degeneration by 6 weeks as measured on ERG
(Figures S1D–S1F), suggesting that Nampt is haplosufficient
during this short timescale.
To confirm that this effect of Nampt deletion was cell
autonomous, we generated mice lacking Nampt specifically
from cone photoreceptors (Namptcone/cone). Although cones
constitute only 3% of the photoreceptors, they are exclusively
Figure 1. Nampt-rod/-rod Mice Exhibit Severe
Retinal Degeneration
For a Figure360 author presentation of Fig-
ure 1, see http://dx.doi.org/10.1016/j.celrep.2016.
08.073#mmc3
(A) Rod-specific deletion of Nampt caused signifi-
cant reduction in Nampt mRNA expression from
rod-enriched retinal isolates (n = 7 isolates/group;
Mann-Whitney U test).
(B) Namptrod/rod retinas had lower NAD+ levels
than NamptF/F retinas (n = 5–8 retinas/group; two-
tailed, unpaired t test).
(C) Rod-enriched retinal isolates from
Namptrod/rod mice had lower NAD+ levels than
those from NamptF/F mice (n = 9–10 pooled
samples/group; one-tailed, unpaired t test).
(D) Representative fundus images from
Namptrod/rod mice demonstrated severe signs of
retinal degeneration including vascular attenuation
and optic nerve atrophy.
(E) Representative retinal sections from
Namptrod/rod mice at 6 weeks stained with H&E
showed significantly reduced outer nuclear layer
thickness (see arrows) with secondary retinal
degeneration.
(F–I) Namptrod/rod mice exhibited impaired
retinal function on ERG (n = 5 NamptF/F mice/10
Namptrod/rod mice; two-way mixed ANOVA with
Bonferroni post hoc test) and reduced photopic
visual acuity (I; n = 5–6 mice/group; two-tailed,
unpaired t test).
Graphs depict mean + SEM (A–C and I) or mean ±
SEM (F–H) (*p < 0.05; **p < 0.01; ***p < 0.001; #p <
0.0001).responsible for precise color and central vision. As expected,
immunohistochemistry revealed reduced intracellular NAMPT
staining (red) within cone photoreceptors (green) in retinal
sections from Namptcone/cone mice, while retinal sections
from NamptF/F mice demonstrated robust cone NAMPT expres-
sion (Figure 2A).
On biomicroscopy, Namptcone/cone mice demonstrated
changes consistent with cone degeneration, including mottling
of the RPE and pallor of the optic nerve (Figure 2B). This struc-
tural degeneration also manifested in functional deficits on
ERG. By 6 weeks, Namptcone/cone mice exhibited mild de-Cell Rclines in their scotopic a- and b-wave am-
plitudes (Figures 2C and 2D). More strik-
ingly, Namptcone/cone mice exhibited
dramatic declines in the amplitudes of
their photopic b-waves (Figure 2E), indi-
cating predominant cone dysfunction.
These structural and functional changes
in Namptcone/cone mice were also
associated with a significant decrease in
photopic visual acuity (Figure 2F). Cumu-
latively, these findings provide strong
support for the essential role of NAMPT-
mediated NAD+ biosynthesis in photore-
ceptor survival, as cell-specific deletionof this key enzyme led to rapid photoreceptor degeneration
and vision loss.
Exogenous NMN Prevents Photoreceptor Degeneration
and Restores Vision
To confirm the importance of NAMPT-mediated biosynthesis in
photoreceptor survival, we tested whether exogenous supple-
mentation with NMN could rescue photoreceptor degeneration
by bypassing the NAMPT-catalyzed reaction. NAMPT catalyzes
the conversion of NAM to NMN and should reduce photo-
receptor death by ameliorating the NAD+ deficiency. We gaveeports 17, 69–85, September 27, 2016 71
Figure 2. Namptcone/cone Mice Exhibit Cone-Specific Degeneration
(A) Cone-specific deletion ofNampt caused reduced intracellular NAMPT staining (red) in cone photoreceptors stained with cone-arrestin (green) and the nuclear
DAPI stain (blue).
(B) Representative fundus images from Namptcone/cone mice demonstrated retinal pigment epithelial cell mottling (arrows) and optic nerve atrophy (arrowhead)
consistent with mild retinal degeneration.
(C–F) Namptcone/cone mice also exhibited impaired retinal function on ERG (n = 8–10 mice/group; two-way mixed ANOVA with Bonferroni post hoc test) and
reduced photopic visual acuity (F; n = 4 mice/group; Mann-Whitney U test).
Graphs depict mean + SEM (F) or mean ± SEM (C–E) (*p < 0.05; **p < 0.01; #p < 0.0001).Namptrod/rod mice daily intraperitoneal injections of NMN
(150 mg/kg) or vehicle alone beginning at postnatal day 5 (P5)
and ending at the time of ERG testing. Strikingly, ERG at 4 weeks
in NMN-treated Namptrod/rod mice revealed significant re-
covery of scotopic and photopic retinal function compared
to vehicle-treated Namptrod/rod mice (Figures 3A–3C). There
was no dramatic effect of NMN on the ERG of NamptF/F controls
(Figures S2A–S2C). Consistently, retinal sections from NMN-
treated Namptrod/rod mice showed rescue of retinal degen-
eration compared to vehicle-treated Namptrod/rod mice, as
manifested by relative preservation of the outer nuclear layer
(Figure 3D).
Correspondingly, daily intraperitoneal NMN injections also
significantly improved retinal function by ERG inNamptcone/cone72 Cell Reports 17, 69–85, September 27, 2016micecompared to vehicle-treatedNamptcone/conemice (Figures
3E–3G). These data clearly demonstrate that NAMPT-mediated
NAD+ biosynthesis is necessary for the survival and function of
both rod and cone photoreceptors, as promoting NAD+ biosyn-
thesis in the retina with NMN supplementation can compensate
for Nampt deletion, thereby reducing photoreceptor death and
improving vision.
Early NAD+ Deficiency Is a Feature of Multiple Mouse
Models of Retinal Dysfunction
Next, we sought to determine whether NAD+ deficiency is an
early feature of other mouse models of retinal disease or
dysfunction, which would support the possibility that NAD+ in-
termediates may have therapeutic potential against a broad
Figure 3. Exogenous NMN Protects Against Retinal Degeneration in Mice Lacking Nampt and May Have Efficacy against Diverse Retinal
Degenerative Diseases
(A–D) Namptrod/rod mice receiving daily intraperitoneal injections of 150 mg/kg NMN beginning at P5 had improved retinal function on ERG (n = 12 vehicle/5
NMN; two-way mixed ANOVAwith Bonferroni post hoc test) compared to vehicle-treated mice, consistent with relative preservation of the outer nuclear layer on
histology (D; see arrows).
(E–G) Nampt-cone/-conemice receiving daily intraperitoneal injections of 150mg/kg NMNbeginning at P5 also had improved retinal function on ERG (n = 9 vehicle/5
NMN; two-way mixed ANOVA with Bonferroni post hoc test).
(H–J) Retinal NAD+ deficiency is a feature of multiple mouse models of retinal dysfunction, including light-induced degeneration (H; n = 10–12/group; two-tailed,
unpaired t test), streptozotocin-induced diabetic retinopathy (I; n = 5/group; two-tailed, unpaired t test), and age-associated retinal dysfunction (J; n = 5/group;
two-tailed, unpaired t test).
Graphs depict mean + SEM (H–J) or mean ± SEM (A–C and E–G) (*p < 0.05; **p < 0.01; ***p < 0.001; #p < 0.0001).
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spectrum of retinal degenerative diseases. Light-induced
degeneration is a well-characterized model that is widely used
to study mechanisms of photoreceptor death (Grimm and
Reme´, 2013) and is known to cause retinal dysfunction, which
can be observed on histology and ERG (Schimel et al., 2011).
We found that there was a significant reduction in retinal NAD+
levels as early as 24 hr following light exposure (Figure 3H). In
addition, we tested whether mice with streptozotocin (STZ)-
induced diabetic retinopathy, whose retinal dysfunction has
been well characterized (Samuels et al., 2015), exhibit retinal
NAD+ deficiency. At 3 weeks after STZ induction, hyperglycemic
mice had a significant reduction in retinal NAD+ compared to
non-hyperglycemic controls (Figure 3I). Finally, it is well known
that there are defects in retinal structure and function in old
mice, such as a decreased number of rod photoreceptors, a
decreased level of total opsin in the retina, and diminished rod
ERG recordings (Kolesnikov et al., 2010; Lin et al., 2016). Consis-
tent with these past reports, we found that 18-month-old wild-
type mice (C57BL/6J) had worse retinal function on ERG
compared to strain-matched 6-month-old mice from the same
source (Figures S2D–S2F). As in light-induced degeneration
and STZ-induced diabetic retinopathy, this age-associated
retinal dysfunction was associated with a significant decline
in retinal NAD+ levels (Figure 3J). These findings support the
idea that NAD+ deficiency may be a shared feature of retinal
dysfunction.
NMN Rescues Retinal Dysfunction in Light-Induced
Degeneration
Since we showed that there is NAD+ deficiency associated with
the retinal dysfunction that follows light-induced degeneration,
we sought to determine whether exogenous NMN supplementa-
tion to rescue NAD+ deficiency would rescue retinal dysfunction.
We gave wild-type mice (129S1/SvImJ) daily intraperitoneal
injections of NMN (300 mg/kg) or vehicle alone beginning
6 days prior to light exposure, on the day of light exposure,
and for 3 days following light exposure (total of ten injections
per mouse). Remarkably, NMN-treated wild-type mice were
more resilient against light exposure and retained improved
retinal function on ERG compared to vehicle-treated mice (Fig-
ures 4A–4C). These findings suggest that the NAD+ deficiency
associated with retinal disease can indeed be rescued by
NAD+ intermediates such as NMN, further supporting the possi-
bility of using NAD+ intermediates to treat retinal degenerative
diseases.
Loss of NAMPT-Mediated NAD+ Biosynthesis Leads to
Metabolic Dysfunction
To provide insight into how NAD+ deficiency leads to retinal
degeneration, we performed transmission electron microscopy
on Namptrod/rod retinas. Although there were no obvious dif-
ferences in mitochondrial ultrastructure at 3 weeks (Figure S3A),
we observed profoundly dysmorphic changes in photoreceptor
inner segments by 4 weeks along with disruption of the outer
segments, which we did not observe in NamptF/F littermates of
the same age (Figure S3B). Of interest, by 4 weeks, the mito-
chondria of Namptrod/rod retinas were rounded and con-
stricted with loss of cristae with a morphology that was distinctly74 Cell Reports 17, 69–85, September 27, 2016different from that observed in NamptF/F littermates (Figure 4D).
In addition, at this time point, we observed degenerative vacu-
oles in the cytoplasm of Namptrod/rod retinas, which appeared
to contain degenerated organelles including ruptured mitochon-
dria (Figure S3C). These results suggest that loss of NAMPT-
mediated NAD+ biosynthesis in photoreceptors leads to
mitochondrial structural irregularities that may lead to or be
associated with defects in mitochondrial function.
To characterize these possible mitochondrial defects, we
performed non-biased metabolomic analysis with liquid chro-
matography-mass spectrometry (LC-MS) and gas chromatog-
raphy-mass spectrometry (GC-MS), comparing retinas isolated
from 3-week-old Namptrod/rod mice from those isolated from
gender-matched NamptF/F littermates. We chose this time point
since it would allow us to identify signs of mitochondrial dysfunc-
tion that precede gross retinal degeneration. The LC-MS results
revealed that although there were no statistically significant
differences, there was a trend toward accumulation of some
acylcarnitine species in Namptrod/rod retinas, suggesting a
possible defect in Krebs cycle efficiency (Figure S3D). In addi-
tion, the GC-MS results revealed that numerous mitochon-
drial metabolites were significantly elevated or reduced in
Namptrod/rod retinas (Figure S3E). To determine whether the
identities of these dysregulated metabolites were suggestive of
defects in certain metabolic pathways, we performedmetabolite
set enrichment analysis with MetaboAnalyst 3.0 (Xia et al., 2015)
using the over-representation analysis algorithm. This analysis
revealed that there are numerous metabolic pathways that are
broadly dysregulated in Namptrod/rod retinas, including protein
biosynthesis, propanoate metabolism, and the citric acid cycle,
among others (Figure 4E).
To confirm that these effects on mitochondrial function were
indeed related to loss of NAMPT function within photoreceptors,
we treated 661W cone photoreceptor-like cells with the pharma-
cological NAMPT inhibitor FK866 (20 mM) and measured reduc-
tive capacity to approximate metabolic activity. NAMPT inhibi-
tion caused considerable reduction of photoreceptor cell
reductive capacity. By 24 hr, FK866-treated cells had 40% of
the reductive capacity of vehicle-treated cells (Figure 5A). By
48 hr, there was an evenmore dramatic effect, with reductive ca-
pacity reduced down to 20% (Figure 5B). Although there was
no cell death at 24 hr (Figure 5C), this loss of reductive capacity
ultimately led to cell death by 48 hr (Figure 5D). This finding high-
lights that metabolic dysfunction, as represented by a decrease
in reductive capacity, precedes cell death.
Since we observed that exogenous NMN supplementation
rescued retinal function in Namptrod/rod and Namptcone/cone
mice, we tested whether NMN supplementation could rescue
the deleterious effects of NAMPT inhibition in photoreceptor
cells. Our results demonstrate that providing FK866-treated
photoreceptors with NMN (100 mM) could completely restore
normal reductive capacities at 24 hr (Figure 5A) and at 48 hr (Fig-
ure 5B) and prevent subsequent cell death (Figure 5D). These
results provide strong evidence for the importance of NAMPT-
mediated NAD
+
biosynthesis in photoreceptors, since we
demonstrate that bypassing the NAMPT-catalyzed reaction
could restore normal reductive capacity and prevent photore-
ceptor cell death.
Figure 4. NAD+ Deficiency Disrupts Retinal Energy Homeostasis and Can Be Rescued with Exogenous NMN
(A–C) Wild-type mice (129S1/SvImJ) receiving intraperitoneal injections of 300 mg/kg NMN were more resilient against light exposure (n = 8/group; two-way
mixed ANOVA with Bonferroni post hoc test) compared to vehicle-treated mice.
(D) Representative electron microscopy images of retinas from 4-week-old Namptrod/rod mice revealed mitochondria that are rounded, disorganized, and with
loss of cristae compared to those from NamptF/F mice.
(E) Namptrod/rod retinas also exhibited significant disruption of numerous metabolic pathways on metabolite set enrichment analysis.
Graphs depict mean ± SEM (A–C) (*p < 0.05).To determine whether these dramatic effects of NAMPT inhibi-
tion were unique to photoreceptors, we tested the effects of
FK866 (20 mM) on the reductive capacity and cell survival ofARPE-19 RPE cells. Of interest, an identical dose of FK866
had no effect on the reductive capacity of RPE cells at 24 hr (Fig-
ure S4A) and only a modest albeit statistically significant effectCell Reports 17, 69–85, September 27, 2016 75
Figure 5. NAMPT Inhibition Causes Metabolic Dysfunction and Photoreceptor Death
(A and B) NAMPT inhibition with 20 mMFK866 caused loss of reductive capacity in 661W cone photoreceptor-like cells by 24 hr and 48 hr (n = 15/group from three
independent experiments; one-way ANOVA with Tukey post hoc test).
(C and D) This metabolic dysfunction caused cell death by 48 hr (n = 14/group from three independent experiments; 1-way ANOVAwith Tukey post hoc test). The
effects of NAMPT inhibition were rescued with 100 mM NMN (A, B, and D).
(E) NAMPT inhibition with 20 mM FK866 led to a significant reduction in total NAD+ in photoreceptor cells by 6 hr, which was restored to near-normal levels with
100 mM NMN (n = 3/group; one-way ANOVA with Tukey post hoc test).
(F) 24 hr of 20 mM FK866 treatment led to undetectable levels of NAD+ (N.D., not detected), which once again was restored with 100 mM NMN (n = 5–7/group).
(G) NAMPT inhibition also caused ATP depletion but in a delayed time frame relative to NAD+ depletion (n = 4/group).
(H and I) FK866-treated photoreceptor cells had reduced oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) at baseline, impaired ECAR
acceleration after oligomycin treatment, and impaired OCR acceleration after FCCP treatment (n = 15–16/group from representative experiment; two-way mixed
ANOVA with Bonferroni post hoc test). 100 mM NMN restored normal metabolic responses (H and I).
(J and K) NAD+-dependent isocitrate dehydrogenase (NAD-IDH/IDH3) activity was reduced in rods isolated fromNamptrod/rod mice compared to those isolated
from NamptF/F mice, even when sufficient NAD+ was added to the reaction mixture (n = 6/group from three independent experiments; two-tailed, unpaired t test)
and despite similar Idh3a expression levels (K; n = 11–13/group from three independent experiments; two-tailed, unpaired t test).
(legend continued on next page)
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on reductive capacity at 48 hr (Figure S4B). Remarkably, FK866
did not reduce RPE cell survival at either 24 hr (Figure S4C) or
48 hr (Figure S4D), demonstrating that RPE cells are more resil-
ient to metabolic dysfunction and thereby protected from cell
death. Ultimately, these results suggest that photoreceptors
are uniquely vulnerable to impairment of NAMPT-mediated
NAD+ biosynthesis and implicate this pathway as a master regu-
lator of photoreceptor metabolism and survival.
NAMPT Inhibition Causes Rapid NAD+ Depletion,
Leading to an ATP Crisis
To further characterize the effects of NAMPT inhibition, we
measured the NAD+ levels in photoreceptor cells after treatment
with FK866 (20 mM). As expected, by 6 hr, FK866-treated photo-
receptor cells contained significantly less total NAD+ compared
to vehicle-treated cells plated at the same density (Figure 5E).
Exogenous NMN supplementation (100 mM) returned NAD+
back to near-normal levels (Figure 5E). After 24 hr, there were un-
detectable levels of NAD+ in FK866-treated cells compared to
vehicle-treated cells (Figure 5F). Similar to the 6 hr time point,
exogenous NMN supplementation for 24 hr prevented FK866-
associated NAD+ depletion, bringing NAD+ back to even higher
levels compared to vehicle-treated cells (Figure 5F). We interpret
these results to indicate that NAMPT inhibition causes rapid
NAD+ deficiency, which likely contributes to the metabolic
dysfunction described above.
To further characterize the connection between NAD+ deple-
tion and cell death, we investigated the time course of NAD+
depletion and its effect on ATP production by simultaneously
measuring NAD+ and ATP content in photoreceptor cells at
various times after treatment with FK866 (20 mM). As above,
we found that FK866 caused rapid NAD+ deficiency. By 6 hr,
NAD+ levels were down to 50% of their original levels (Fig-
ure 5G). NAD+ depletion continued rapidly, dropping to 15%
by 12 hr and to undetectable levels by 24 hr (Figure 5G). NAMPT
inhibition also caused ATP depletion, but ATP levels did not
decline after 6 hr of FK866 treatment and dropped only modestly
to70%of the original levels by 12 hr (Figure 5G). By 24 hr, how-
ever, ATP levels had dropped down to 10% of the original
levels (Figure 5G). The temporal relationship between NAD+
and ATP depletion suggests that the ATP crisis is a downstream
effect of NAD+ deficiency-associated metabolic dysfunction.
To confirm the connection between NAD+ availability, ATP
content, metabolic function, and cell survival, we also measured
the NAD+ and ATP levels in RPE cells after NAMPT inhibition.
Consistent with the mild effects on metabolic function (Figures
S4A and S4B) and the lack of effect on cell survival (Figures
S4C and S4D), 24 hr of FK866 treatment (20 mM) caused only a
60% reduction in total NAD+ levels (Figure S4E), a smaller
effect than that observed after 24 hr of FK866 treatment in photo-
receptor cells. This intermediate decrease in total NAD+ levels
was accompanied by a concomitant increase in ATP levels (Fig-(L andM) The activities of other NAD+-dependent enzymes alpha-ketoglutarate de
WhitneyU test) and malate dehydrogenase (MDH; n = 7/group from three indepen
were restored with exogenous NAD+.
Graphs depict mean + SEM (A–F and J–M) or mean ± SEM (G–I) (*p < 0.05; **
FK + NMN).ure S4F), drastically different from the severe ATP depletion
exhibited by photoreceptor cells. These findings suggest that
photoreceptor cells are more vulnerable to perturbations in
NAD+ biosynthesis compared to other non-photoreceptor eye
cells, such as RPE cells.
NAMPT Inhibition Impairs Basal Metabolism and the
Normal Response to Metabolic Stress
The rapid decline in ATP in photoreceptor cells within 24 hr
of FK866 treatment suggests that NAMPT inhibition causes sig-
nificant metabolic dysfunction. To characterize what elements of
metabolic function were impaired, we treated photoreceptor
cells with FK866 (20 mM) and profiled various aspects of meta-
bolism by measuring oxygen consumption rate (OCR) as a mea-
sure of aerobic respiration and extracellular acidification rate
(ECAR) as a measure of glycolytic flux. We measured these pa-
rameters of metabolic function at baseline and under various
conditions of stress induced by sequential treatments with oligo-
mycin, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(FCCP), and antimycin A/rotenone.
At baseline, FK866-treated photoreceptor cells exhibited
reduced OCR and ECAR (Figures 5H and 5I), indicating that
NAMPT inhibition caused reduced basal oxidative respiration
and basal glycolytic flux. While vehicle-treated cells responded
appropriately to the ATP synthase inhibitor oligomycin by shifting
toward glycolytic metabolism (reduced OCR and increased
ECAR), FK866-treated photoreceptor cells were unable to shift
toward glycolytic metabolism (Figures 5H and 5I). Moreover,
while vehicle-treated cells responded appropriately to the iono-
phore FCCP by elevating their oxidative respiration (increased
OCR), FK866-treated photoreceptor cells were unable to accel-
erate oxidative respiration in response to metabolic stress
(Figure 5H). NMN supplementation restored normal baseline
metabolism and the appropriate responses to stress (Figures
5H and 5I), confirming that these phenotypes were specific to
NAD+ deficiency.
To confirm that these effects on metabolic function were spe-
cific to NAMPT inhibition, we performed Nampt knockdown
in photoreceptor cells. Partial reduction of NAMPT-mediated
NAD+ biosynthesis through Nampt knockdown in photoreceptor
cells caused a reduction in NAD+ levels (Figure S5A) within 24 hr
after knockdown. Although this intermediate reduction in NAD+
did not affect reductive capacity (Figure S5B) or cell survival at
the early 48-hr time point (Figure S5C), it did impair the ability
of photoreceptor cells to maximally accelerate oxidative respira-
tion in response to FCCP (Figures S5D and S5E), further reinforc-
ing the importance of NAMPT-mediated NAD+ biosynthesis for
maintaining mitochondrial homeostasis in photoreceptors.
Taken together, these data confirm the importance of NAMPT-
mediated NAD+ biosynthesis for maintaining photoreceptor
glycolytic and mitochondrial function, both at baseline and in
response to metabolic stress, and highlight a NAMPT-specifichydrogenase (AGDH; n = 5/group from three independent experiments; Mann-
dent experiments; two-tailed, unpaired t test) in rods from Namptrod/rod mice
p < 0.01; ***p < 0.001; #p < 0.0001; red: vehicle versus FK; blue: FK versus
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effect due to the ability of NMN to restore normal metabolic re-
sponses. Importantly, we observed these signs of metabolic
dysfunction after 24 hr of FK866 treatment prior to when we
observed the effects on photoreceptor cell viability. Once again,
these results highlight that glycolytic andmitochondrial dysfunc-
tion precede and therefore likely cause photoreceptor cell death.
NAD+ Deficiency Causes NAD-IDH Dysfunction
Our in vitro and in vivo results suggest that there are defects
in oxidative metabolism in photoreceptors under conditions of
NAD+ deficiency. To more specifically characterize these de-
fects in oxidative metabolism, we tested the activity of three en-
zymes of the Krebs cycle that require NAD+ as a coenzyme:
NAD+-dependent isocitrate dehydrogenase (NAD-IDH/IDH3),
alpha-ketoglutarate dehydrogenase (AGDH), and malate dehy-
drogenase (MDH). This fact that these enzymes require NAD+
as a coenzyme provides the opportunity to determine whether
their enzymatic dysfunction is caused solely by loss of NAD+
as a coenzyme. If loss of NAD+ as a coenzyme were solely
responsible for enzymatic dysfunction, we would expect to be
able to restore enzymatic function simply by providing sufficient
NAD+ to the reaction mixture.
We found that NAD-IDH activity was significantly lower in rods
isolated from Namptrod/rod retinas compared to those isolated
from NamptF/F retinas, even when sufficient NAD+ was supplied
in the reaction (Figure 5J) and despite similar NAD-IDH expres-
sion levels (Figure 5K). These findings suggest that NAD-IDH
dysfunction cannot be explained by loss of NAD+ as a coenzyme
alone. Of significant interest, the rod AGDH and MDH activities
were completely rescued by NAD+ (Figures 5L and 5M), indi-
cating selective enzymatic dysfunction. These findings not only
characterize one specific aspect of mitochondrial dysfunction
but also suggest that NAD+ plays important roles in regulating
metabolism in addition to its role as a coenzyme.
SIRT3 and SIRT5 Play Important Roles in Photoreceptor
Survival
In addition to serving as a coenzyme for crucial steps of glycol-
ysis and the Krebs cycle, NAD+ also serves as a cosubstrate
for NAD+-consuming enzymes, including the sirtuins. Of the
seven sirtuin family members, three of them (SIRT3, SIRT4,
and SIRT5) are known to regulate mitochondrial function (Lau-
rent et al., 2013; Yang et al., 2007; Zhang et al., 2015). Because
other sirtuin family members have been shown to play crucial
roles in regulating the survival of retinal cells (Jaliffa et al.,
2009; Silberman et al., 2014) and because sirtuins depend
on NAD+ availability for optimal function (Satoh and Imai,
2014), we hypothesized that NAD+ deficiency may also impair
mitochondrial sirtuin activity, contributing to mitochondrial
dysfunction.
To determine whether the mitochondrial sirtuins are essential
for photoreceptor survival, we performed individual and com-
bined knockdown of SIRT3, SIRT4, and SIRT5 in photoreceptor
cells. Individual knockdown of SIRT3 and SIRT5 caused signifi-
cant reduction in reductive capacity compared to knockdown
by negative control (Figure 6A). Interestingly, individual knock-
down of SIRT4 did not diminish reductive capacity, highlighting
the specificity of the effect of SIRT3 and SIRT5 (Figure 6A). Com-78 Cell Reports 17, 69–85, September 27, 2016bined SIRT3 and SIRT5 knockdown had a synergistic effect,
leading to significantly lower reductive capacity compared to
either single knockdown alone (Figure 6A). Of note, NMN was
not able to rescue the effect on reductive capacity in the
SIRT3/SIRT5 double knockdown (Figure 6A), suggesting that
exogenous NMN cannot protect against SIRT3/SIRT5 deletion.
This decline in reductive capacity secondary to SIRT3/SIRT5
knockdownwas also accompanied by progressive cell death. In-
dividual knockdown of SIRT3 and SIRT5 caused significant
reduction in cell survival compared to knockdown by negative
control (Figure 6B). Again, individual knockdown of SIRT4 had
no effect on cell viability (Figure 6B), highlighting the specificity
of the SIRT3/SIRT5 effect. Once again, combined SIRT3 and
SIRT5 knockdown had a more profound effect on cell death
compared to either individual knockdown alone (Figure 6B).
Consistently, NMN supplementation did not rescue the cell
death caused by combined SIRT3/SIRT5 double knockdown
(Figure 6B).
To test whether loss of SIRT3 and SIRT5 causesmitochondrial
dysfunction that is similar to that caused by NAD+ deficiency, we
performed individual and combined SIRT3 and SIRT5 knock-
downs in photoreceptors and measured the NAD-IDH activity
24 hr after transfection. We found that knocking down SIRT3,
SIRT5, or both SIRT3 and SIRT5 in photoreceptor cells recapit-
ulated NAD-IDH dysfunction (Figure 6C). The fact that SIRT3
and SIRT5 knockdowns phenocopy the NAD-IDH dysfunction
observed in rods isolated from Namptrod/rod retinas suggests
that SIRT3 and SIRT5 may play a role in governing the metabolic
dysfunction associated with NAD+ deficiency.
To test the role of SIRT3 and SIRT5 in retinal function in vivo,
we tested mice lacking SIRT3 and SIRT5. Both SIRT3KO and
SIRT5KO mice had normal-appearing fundi on biomicroscopy
(Figures S6A and S6B) and normal retinal function on ERG
compared to strain-matched controls (Figures S6C–S6H). How-
ever, since many studies report that SIRT3 and SIRT5 regulate
many of the same protein targets and even the same lysine
residues within the same protein (Hebert et al., 2013; Park
et al., 2013; Rardin et al., 2013a, 2013b; Schwer et al., 2009;
Sol et al., 2012; Still et al., 2013), it is possible that SIRT3 and
SIRT5 can compensate for one another. To test this possibility,
we also tested mice lacking multiple mitochondrial sirtuins.
Although SIRT3KOSIRT5KO mice had normal retinal function at
baseline (Figures S6I–S6K), we could not yet conclude that
SIRT3 and SIRT5 are inessential for retinal function, since previ-
ous studies have reported that mice lacking mitochondrial sir-
tuins rarely show striking phenotypes (Lombard et al., 2007; Yu
et al., 2013) until they are challenged by specific stimuli such
as fasting or a high-fat diet (Hirschey et al., 2011). To this end,
we tested whether SIRT3KOSIRT5KO mice are more vulnerable
to retinal degeneration after exposure to light. We found that
SIRT3KOSIRT5KO mice were strikingly more vulnerable to retinal
degeneration upon light stress compared to SIRT3hetSIRT5het
controls as manifested by retinal dysfunction on ERG (Figures
6D–6F) when tested 4 days after light treatment. Interestingly,
SIRT3hetSIRT5KO and SIRT3KOSIRT5het mice demonstrated an
intermediate degenerative phenotype (Figures 6D–6F), support-
ing the notion that SIRT3 andSIRT5 synergistically regulatemito-
chondrial function in photoreceptors. Together, these results
Figure 6. SIRT3 and SIRT5 Are Essential for Photoreceptor Survival
(A) Individual SIRT3 and SIRT5 knockdown but not SIRT4 knockdown caused significant loss of reductive capacity relative to negative control (NC); combined
SIRT3/SIRT5 knockdown caused significantly more loss of reductive capacity than individual knockdowns, which could not be rescued with NMN (n = 6/group
from representative experiment; one-way ANOVA with Tukey post hoc test).
(B) Individual SIRT3 and SIRT5 knockdown but not SIRT4 knockdown caused significant cell death relative to negative control (NC); combined SIRT3/SIRT5
knockdown caused significantly more cell death than individual knockdowns, which could not be rescued with NMN (n = 18/group from three independent
experiments; one-way ANOVA with Tukey post hoc test).
(C) Individual and combined SIRT3/SIRT5 knockdowns recapitulated NAD-IDH dysfunction compared to negative control (NC; n = 3/group from three inde-
pendent experiments; one-way ANOVA with Tukey post hoc test).
(D–F) Mice lacking SIRT3 and SIRT5 (SIRT3KOSIRT5KO) were significantly more vulnerable to light-induced degeneration (LID) compared to SIRT3hetSIRT5het
mice, while SIRT3KOSIRT5het and SIRT3hetSIRT5KO mice exhibited intermediate vulnerability to LID (n = 5–7 mice/group; two-way mixed ANOVA with Bonferroni
post hoc test).
Graphs depict mean + SEM (A–C) or mean ± SEM (D–F) (*p < 0.05; **p < 0.01; ***p < 0.001; #p < 0.0001; p^ < 0.05 relative to both SIRT3KD and SIRT5KD; red:
SIRT3hetSIRT5het versus SIRT3KOSIRT5KO; brown: SIRT3KOSIRT5het versus SIRT3KOSIRT5KO; gray: SIRT3hetSIRT5KO versus SIRT3KOSIRT5KO).provide strong evidence that SIRT3 and SIRT5 not only are
important for maintaining photoreceptor survival but also have
distinct, non-redundant roles in regulating retinal homeostasis.
NAMPT Inhibition Causes SIRT3 Dysfunction
Since we found that SIRT3 and SIRT5 are essential for photore-
ceptor survival, we sought to determine whether NAD+ defi-
ciency caused by NAMPT inhibition impairs SIRT3 and SIRT5
function in photoreceptor cells. Since SIRT3 regulates pre-
dominantly protein acetylation (Parihar et al., 2015) and SIRT5
regulates predominantly protein succinylation, malonylation,
and glutarylation (Du et al., 2011; Nishida et al., 2015; Papanico-
laou et al., 2014; Tan et al., 2014), we tested whether NAMPT
inhibition modulates the acylation of mitochondrial proteins in
photoreceptor cells. We found that mitochondrial lysates gener-
ated from photoreceptor cells treated with FK866 (20 mM) for
24 hr showed obvious hyperacetylation (Figures 7A and 7B), indi-
cating SIRT3 dysfunction. Normal acetylation patterns were
restored with NMN (Figures 7A and 7B), confirming that this hy-
peracetylation was specific to NAMPT inhibition. Although therewere clear acetylation changes, these mitochondrial lysates
demonstrated only modest changes in succinylation (Figures
7C and 7D) and no obvious differences in malonylation (Fig-
ure S7A) or glutarylation (Figure S7B), suggesting that NAD+ defi-
ciency primarily impairs SIRT3 function.
To confirm that these effects were caused by NAMPT inhibi-
tion rather than being secondary to metabolic dysfunction,
we measured the activity of SIRT3 and SIRT5 in the mitochon-
drial lysates generated from FK866-treated photoreceptor cells.
Consistent with our western blots, mitochondrial lysates gener-
ated from FK866-treated photoreceptor cells had a significant
reduction in SIRT3 activity compared to mitochondrial lysates
generated from vehicle-treated cells (Figure 7E). There was,
however, no difference in SIRT5 activity (Figure 7F). Taken
together, these results demonstrate that NAD+ deficiency leads
to dysregulation of the mitochondrial acylome primarily through
impairment of SIRT3 function. Since we show that SIRT3 is
important for photoreceptor survival, this NAD+-deficiency-
associated impairment of SIRT3 activity likely contributes
to the mitochondrial dysfunction observed in photoreceptorsCell Reports 17, 69–85, September 27, 2016 79
Figure 7. NAD+ Deficiency Impairs Mito-
chondrial Sirtuin Function
(A and B) NAMPT inhibition caused selective
mitochondrial protein hyperacetylation (n = 4 bio-
logical replicates from two independent blots;
one-way ANOVA with Tukey post hoc test).
(C and D) NAMPT inhibition caused only modest
changes in mitochondrial protein succinylation
(n = 6 biological replicates from three independent
blots; one-way ANOVA with Tukey post hoc test).
(E and F) NAD+ deficiency impaired SIRT3 activity
(n = 6/group; two-tailed, unpaired t test), but not
SIRT5 activity (F; n = 15–16/group; two-tailed,
unpaired t test).
Graphs depict mean + SEM (B andD–F) (**p < 0.01;
***p < 0.001).lacking Nampt, providing additional mechanistic evidence for
why NAMPT-mediated NAD+ biosynthesis is essential for mito-
chondrial homeostasis, photoreceptor survival, and vision.
DISCUSSION
NAD+ has numerous functions in diverse biological processes,
including metabolism, circadian rhythms, aging, and neurode-
generation (Alano et al., 2010; Garten et al., 2009; Gerdts
et al., 2015; Imai and Yoshino, 2013; Mouchiroud et al., 2013;
Nakahata et al., 2009; Ramsey et al., 2009; Stein et al., 2014;
Zhou et al., 2015). In the current study, we demonstrate
that NAMPT-mediated NAD+ biosynthesis is indispensable for
photoreceptor survival and vision. Using loss-of-function ap-
proaches, we show that disrupting NAMPT-mediated NAD+
biosynthesis in rod and cone photoreceptors leads to photore-
ceptor death, retinal degeneration, and blindness. By testing
the effects of NAMPT inhibition on non-photoreceptor cells, we
confirm that photoreceptors are uniquely susceptible to pertur-
bations in NAD+ biosynthesis.
Moreover, we demonstrate that, in photoreceptors, loss of
NAMPT-mediated NAD+ biosynthesis leads to NAD+ deficiency,
significant glycolytic and mitochondrial dysfunction under basal
conditions, and the inability to respond appropriately to meta-
bolic stress, which ultimately lead to photoreceptor death and
retinal degeneration. Corresponding with this energetic failure,
metabolic profiling of retinas from Namptrod/rod mice revealed80 Cell Reports 17, 69–85, September 27, 2016dysregulation of numerous metabolic
pathways. Of interest, there was a trend
(p = 0.0704) toward dysregulation of the
citric acid cycle, a key pathway in oxida-
tive metabolism. The trends toward accu-
mulation of various acylcarnitine species
also support a failure of Krebs cycle effi-
ciency. These hallmarks of metabolic
dysfunction can be identified prior to cell
death and vision loss, supporting the
possibility of probing mitochondrial func-
tion to predict subsequent photoreceptor
death (Perron et al., 2013). These find-
ings are interesting, especially consid-ering recent studies that show that photoreceptors have limited
mitochondrial reserve capacity, which may make them suscep-
tible to defects in energy homeostasis (Kooragayala et al., 2015).
We speculate that defects in the Krebs cycle cause broad en-
ergetic failure, which contributes to downstream defects in
numerous metabolic pathways, such as protein biosynthesis
and propanoate metabolism. Further studies are necessary to
explore the precise connection between these phenomena.
Our results also identify that NAD+ deficiency leads to selec-
tive enzymatic dysfunction and that cell death is unlikely to be
caused by loss of NAD+ as a coenzyme alone. When we tested
the activity of the three NAD+-dependent enzymes of the Krebs
cycle in rods isolated from Namptrod/rod retinas, the activity
of only one of the three, NAD-IDH, could not be rescued by
providing sufficient NAD+ as a coenzyme, while the activity of
the other NAD+-dependent Krebs cycle enzymes, AGDH and
MDH, was restored by providing exogenous NAD+. This result
stresses the importance of NAD-IDH in maintaining metabolic
homeostasis in photoreceptors. In support, the retina has been
shown to be highly dependent on NAD-IDH and exquisitely sen-
sitive to defects in NAD-IDH function, such that mutations in
NAD-IDH that impair its catalytic activity cause RP (Hartong
et al., 2008). Of significant interest, these RP patients have
normal NADP+-dependent IDH (i.e., NADP-IDH or IDH1/IDH2)
activity and no other manifestations of disease despite the fact
that they carry this mutation in all cells of their body (Hartong
et al., 2008). This finding suggests that in contrast with most
organ systems, the retina uniquely relies on the NAD+-depen-
dent form of IDH (Hartong et al., 2008).
We further demonstrate that SIRT3 and SIRT5 both play
important roles in photoreceptor survival and that NAD+ defi-
ciency leads to predominately SIRT3 dysfunction. Our results
agree with past studies reporting that other sirtuin family mem-
bers, including SIRT1 (Jaliffa et al., 2009) and SIRT6 (Silberman
et al., 2014), play roles in photoreceptor survival and survival of
other retinal cells. Interestingly, we demonstrate that the delete-
rious effects of SIRT3 and SIRT5 deletion are synergistic. These
findings strongly suggest that SIRT3 and SIRT5 are not redun-
dant, even though they may regulate the acylation status of the
same mitochondrial proteins and even the same lysine residues
within the same proteins (Hebert et al., 2013; Park et al., 2013;
Rardin et al., 2013a, 2013b; Schwer et al., 2009; Sol et al.,
2012; Still et al., 2013).
Based on our results, we hypothesize that SIRT3 dysfunction
caused by NAD+ deficiency may contribute to mitochondrial
dysfunction by causing aberrant hyperacetylation of key mito-
chondrial proteins, such as NAD-IDH. This possibility that
SIRT3 dysfunction is linked to decreased NAD-IDH activity
is supported not only by our ability to recapitulate NAD-IDH
dysfunction with SIRT3 knockdown but also by the fact that
NAD-IDH has been identified as a target of SIRT3 (Hebert
et al., 2013; Rardin et al., 2013b; Schwer et al., 2009; Sol et al.,
2012; Still et al., 2013). Further studies are needed to explore
this possibility and to extend these findings in vivo, perhaps us-
ing new technologies such as clustered regularly interspaced
short palindromic repeats (CRISPR)/Cas9 to delete Nampt
selectively from photoreceptors.
Cumulatively, these findings provide unique insights that point
to the dominant mammalian NAD+ biosynthesis pathway as a
master regulator of photoreceptor metabolism. Human retinal
degenerations encompass a broad spectrum of diseases that
include seemingly unrelated disorders such as LCA and RP,
which have been associated with mutations in enzymes involved
in NAD+ biosynthesis (Chiang et al., 2012; Falk et al., 2012; Koe-
nekoop et al., 2012; Perrault et al., 2012) and the Krebs cycle
(Hartong et al., 2008). Despite these genetic insights, the mech-
anisms underlying these conditions and what ultimately causes
photoreceptor degeneration in these genotypically diverse dis-
orders are poorly understood. We propose a model linking
NAD+ biosynthesis, SIRT3/SIRT5, and metabolism in photore-
ceptors, which may connect these diverse retinal neurode-
generations at the molecular level.
Remarkably, our studies also demonstrate exogenous
NMN supplementation to bypass the NAMPT-catalyzed reac-
tion can restore normal NAD+ levels in photoreceptor cells
despite NAMPT inhibition and reduce photoreceptor death
in Namptrod/rod mice. In photoreceptor cells subjected to
NAMPT inhibition, NMN supplementation prevented metabolic
dysfunction and cell death by restoring normal basal glycolytic
and mitochondrial function and the ability to respond appropri-
ately to metabolic stress. This therapeutic effect is likely ex-
plained by the importance of NAD+ not only to perform its
coenzyme role in various steps of the Krebs cycle and glycolysis
but also to maintain optimal SIRT3 activity. We show that multi-
ple mouse models of retinal dysfunction, including light-induceddegeneration, STZ-induced diabetic retinopathy, and age-
associated retinal dysfunction, all exhibit early retinal NAD+
deficiency. Moreover, the retinal dysfunction associated with
light-induced degeneration can be partially rescued with NMN.
These findings offer powerful therapeutic avenues for degenera-
tive diseases of the eye and are supported by past studies
exploring the therapeutic applications of NAD+ supplementation
in light-induced degeneration (Bai and Sheline, 2013), noise-
induced hearing loss (Brown et al., 2014), and high-fat-diet-
and age-induced metabolic complications (Canto´ et al., 2012;
Ramsey et al., 2008; Stein and Imai, 2014; Yoshino et al., 2011).
Once successfully implemented, this treatment strategy
would be far-reaching, since it could be implemented formultiple
diseases with diverse pathogenic mechanisms, including not
only inherited forms of retinal degenerations but also other blind-
ing diseases characterized by a final pathway of photoreceptor
death such as AMD and diabetic retinopathy. Given the global
importance of NAD+ biosynthesis andmitochondrial dysfunction
in neurons, our findings may also be broadly relevant to other
systemic neurodegenerative diseases such as Alzheimer’s
disease, where NAD+ intermediate supplementation may be
neuroprotective.
EXPERIMENTAL PROCEDURES
Mice
All animal experiments were approved by the Animal Studies Committee and
performed in accordance with the Washington University School of Medicine
Animal Care andUse guidelines. Namptflox/flox (NamptF/F) micewere previously
characterized (Rongvaux et al., 2008) and were provided by Dr. Shin-ichiro
Imai. To generate mice lacking Nampt specifically from rod photoreceptors,
we crossed NamptF/F mice with mice carrying one copy of the Rhodopsin-
iCre75 transgene, which were provided by Dr. Ching-Kang Jason Chen and
have been previously characterized (Li et al., 2005). To generate mice lacking
Nampt specifically from cone photoreceptors, we crossed NamptF/F mice with
mice carrying one copy of the human red/green pigment-Cre (HRGP-Cre)
transgene, which were provided by Dr. Yun Le and have been previously char-
acterized (Le et al., 2004). We received 6-month-old and 18-month-old wild-
type C57BL/6J mice from the National Institutes on Aging (Bethesda, MD)
and purchased streptozotocin (STZ)-induced hyperglycemic mice (C57BL/
6J) from Jackson Laboratory. We also purchased SIRT3/, SIRT5/, and
the appropriate strain-matched wild-type mice (129S1/SvImJ for SIRT3/
and B6129SF2/J for SIRT5/) from Jackson Laboratory.
Cells and Reagents
We routinely cultured 661W cone photoreceptor-like cells, provided by Dr.
Muayyad Al Ubaidi (Tan et al., 2004), in DMEM with 1 g/L glucose and
110 mg/L sodium pyruvate (Thermo Fisher Scientific) supplemented with
10% fetal bovine serum (FBS; Sigma) and 1% penicillin-streptomycin (Thermo
Fisher Scientific). We prepared stock solutions of FK866 (Santa Cruz Biotech-
nology) at 200 mM in DMSO. We purchased NMN from Sigma and dissolved it
directly in cell culture media, prepared as described above.
Real-Time PCR in Rod-Enriched Samples
We generated rod-enriched samples by vortexing dissected whole retinas for
60 s at medium speed and centrifuging the resulting supernatant at 12,8003 g
for 10 min. We extracted total RNA from the resulting pellet with the RNeasy
Mini Kit (QIAGEN), prepared cDNA with the High Capacity cDNA Reverse
Transcription Kit (Life Technologies), and performed PCR amplification of
cDNA using TaqMan probe-based gene expression assays (Life Tech-
nologies) as described previously (Kelly et al., 2007). We used probes for
Nampt (Mm01293560_m1) and Idh3a (Mm00499674_m1) normalized to
ActB (Mm00607939_s1) or Rho (Mm01184405_m1) with the DDCT method.Cell Reports 17, 69–85, September 27, 2016 81
Retinal Imaging
We performed digital color fundus photography using the Micron III animal
fundus camera (Phoenix Research Laboratories). Prior to fundus imaging,
we anesthetized mice with an intraperitoneal injection of 86.9 mg/kg ketamine
and 13.4 mg/kg xylazine and administered 1.0% tropicamide eye drops
(Bausch & Lomb) to dilate the pupils.
Histology and Immunohistochemistry
After euthanizing the mice, we enucleated the eyes and fixed them overnight in
10% formalin. Next, we embedded the eyes in methacrylate and prepared
eight to ten sections of 6–8 mm thickness cut at different planes for each
eye. We stained slides with H&E, rabbit anti-NAMPT(161-173) (B5812-
200UL; Sigma), and rabbit anti-cone arrestin (AB15282; Millipore). We ac-
quired images with an Olympus FV1000 upright confocal microscope with
UV-sensitive (405), multi-argon (458, 488 & 513) and helium-neon (543
and 633) lasers, and a Plan-Apo N 603 oil objective (numerical aperture
[NA] = 1.42).
Electroretinography
We performed ERG as previously described (Hennig et al., 2013) by using the
UTAS-E3000 Visual Electrodiagnostic System running EM for Windows (LKC
Technologies). We extracted quantitative measurements from the ERG wave-
forms using an existing Microsoft Excel macro that defines the a-wave ampli-
tude as the difference between the average pre-trial baseline and the most
negative point of the average trace and defines the b-wave amplitude as the
difference between this most negative point to the highest positive point,
without subtracting oscillatory potentials.
Photopic Visual Acuity
We measured mouse photopic visual acuity under standard photopic condi-
tions (1.85 log cd m2) by testing the optokinetic reflex with the OptoMotry
System (CerebralMechanics) as described previously (Kolesnikov et al.,
2011; Umino et al., 2008).
Transmission Electron Microscopy
To perform transmission electron microscopy, we dissected enucleated eyes
to remove the cornea and lens and fixed eye cups for 4 hr at room temper-
ature in 2% paraformaldehyde/2.5% glutaraldehyde (Polysciences) diluted
in 100 mM sodium cacodylate (pH 7.2). We then washed the fixed eye cups
in cacodylate buffer and post-fixed them in 1% osmium tetroxide (Polyscien-
ces) for 1 hr. We then rinsed the postfixed eye cups extensively in deionized
H2O prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella) for
1 hr. Following several rinses, we dehydrated the stained eye cups with a
graded series of ethanol solutions and embedded them in Eponate 12 resin
(Ted Pella). We cut 95-nm sections with a Leica Ultracut UCT ultramicrotome
(LeicaMicrosystems), stained the sections with uranyl acetate and lead citrate,
and imaged them on a JEOL 1200 EX transmission electron microscope (JEOL
USA) equipped with an AMT 8-megapixel digital camera (Advanced Micro-
scopy Techniques).
Metabolomic Analysis
We isolated retinas at the same time of day after restricting oral nutrient
intake for 4 hr. We pooled six retinas per group and snap-froze them in
liquid nitrogen. We then added ammonium bicarbonate-buffered solution
to the tissue pellets and transferred these tissue suspensions to tubes for
subsequent metabolite extraction. We extracted intracellular metabolites
and culture media samples into cold methanol:acetonitrile (ACN):water
(H2O), dried them, derivatized them to their tert-butyldimethylsilyl esters
(tBDMS), and then analyzed them on an Agilent 7200 GC-quadrupole
time-of-flight (QTOF)-MS operating in electron impact ionization mode.
We dried an aliquot of each extract and dissolved it in ACN:H2O for subse-
quent LC-QTOF-MS analysis. We performed metabolite set enrichment
analysis with MetaboAnalyst 3.0 (Xia et al., 2015) by inputting the list of dys-
regulated metabolites with a statistically significant difference (corrected
p value < 0.05) and a fold-change >1.10. These data were processed with
the over-representation algorithm and the metabolic-pathway-associated
metabolite set library.82 Cell Reports 17, 69–85, September 27, 2016Reductive Capacity Assay
To quantify reductive capacity, we used the Cell Proliferation Reagent WST-1
(Roche Applied Science) according tomanufacturer’s instructions. In short, we
washed cells once with PBS after the desired treatment and replaced the
media with fresh media containing the WST-1 assay solution at a 1:10 dilution.
After 2 hr of incubation at 37C, we measured absorbance at 450 nm with the
SpectraMax 190 Absorbance Microplate Reader (Molecular Devices).
Cell Survival Assay
To determine cell survival, we used the cell-permeant dye calcein AM (Thermo
Fisher Scientific) according to manufacturer’s instructions. In short, we
washed cells once with PBS after the desired treatment and replaced the me-
dia with calcein AM diluted in PBS (working concentration of 2 mM). After
30 min at 37C, we measured fluorescence at 485 nm excitation/520 nm
emission with the Infinite 200 PRO (Tecan).
Quantification of NAD+ and ATP Levels with HPLC
To quantify the NAD+ and ATP levels of mouse retina, pooled rod-enriched iso-
lates, or 661W cells, we performed reverse-phase high-performance liquid
chromatography (HPLC) as described previously (Yoshino and Imai, 2013).
We quantifiedNAD+ and ATP levels based on the peak area on theHPLC spec-
trogram relative to a standard curve and normalized these values to tissue
weights for retinas, number of retinas for rod-enriched isolates, or based on
cell number.
OCR and ECAR Measurements
We performed detailed metabolic characterization of 661W cells after NAMPT
inhibition using an XF96 Extracellular Flux Analyzer (Seahorse Bioscience).
After the desired treatment, we washed the cells three times and left them in
180 ml prewarmed bicarbonate-free DMEM (pH 7.4). After 30–60 min in a
non-CO2 incubator, we simultaneouslymeasured the OCR and ECAR to quan-
tify oxidative respiration and glycolytic flux, respectively, both at baseline
and after sequential treatments of 1.5 mMoligomycin, 1.0 mMcarbonyl cyanide
4-(trifluoromethoxy) phenylhydrazone (FCCP), and a combination of 1.0 mM
antimycin A and 1.0 mM rotenone. Each 5-min measurement period was
preceded by 2 min of mixing and a 1-min pause; we made three sequential
measurements per treatment condition.
SIRT3-5 and Nampt Knockdown in 661W Cells
We transfected 661W cells with custom LNA longRNA GapmeRs reagents
(Exiqon) targeting SIRT3, SIRT4, or SIRT5 at a final concentration of 100 nM
and commercially available small interfering RNA (siRNA) targeting Nampt
(Mm_Pbef1_5; QIAGEN) at a final concentration of 50 nM. In short, we seeded
661W cells and allowed them to adhere for 30 min. We prepared the transfec-
tion complexes by incubating the appropriate GapmeR/siRNA with Lipo-
fectamine RNAiMAX transfection reagent (Invitrogen) for 5 min at room
temperature (1.0 ml or 2.4 ml of RNAiMAX per well for the 96-well and 24-well
plate formats, respectively). We confirmed knockdown efficiency with real-
time PCR.
Light-Induced Degeneration
We performed light-induced degeneration as described previously (Grimm
and Reme´, 2013). In short, we dilated pupils with two sequential drops of
1.0% atropine sulfate and 1.0% tropicamide (Bausch & Lomb) and then
exposed the mice to 13,000 lux from fluorescent lights suspended directly
over the mice. We placed the mice in clear plastic cages that were surrounded
on all sides with reflective aluminum foil and re-dilated pupils with two addi-
tional drops every 2 hr. We assessed retinal function 4 days following light-
induced degeneration with ERG as described above. All the mice we tested
carried the RPE65Leu/Leu variant, making them equally vulnerable to light-
induced degeneration (Wenzel et al., 2001).
Krebs Cycle Enzymatic Activity Assays
We performed retinal dissociation by incubating dissected retinas in 12 U/mL
papain (Sigma) and 5 mM L-cysteine in DMEM for 30 min on a small vibrating
aquarium pump at room temperature. After washing away residual papain with
five exchanges to fresh DMEM, we triturated the samples with fire-polished
Pasteur pipets. We then separated rod photoreceptors with the EasySEP
Mouse phycoerythrin (PE) Positive Selection Kit (STEMCELL Technologies)
and PE-conjugated anti-CD73 antibodies (Miltenyi Biotec). We measured the
enzymatic activity of NAD+-dependent isocitrate dehydrogenase (NAD-IDH/
IDH3), alpha-ketoglutarate dehydrogenase (AGDH), and malate dehydroge-
nase (MDH) in these rods with assay kits from Sigma according to the manu-
facturer’s instructions. We normalized enzymatic activity to total protein and/
or viable rod cell number.
Western Blotting for Mitochondrial Protein Acylation
We isolated mitochondria from 661W cells as described previously (Frezza
et al., 2007). We denatured mitochondrial lysates in NuPAGE LDS Sample
Buffer and NuPAGE Sample Reducing Agent (Thermo Fisher Scientific) for
10 min at 70C, loaded them into 4%–12% Novex Bis-Tris Protein Gels, and
then ran them at 50 V for 15 min followed by 150 V for 60 min. We transferred
the gel to a 0.2 mm nitrocellulose membrane (Bio-Rad) in transfer buffer
(192mMglycine, 25 nM Tris-base, and 10%methanol) for 60 min at a constant
current of 400mA.We blocked themembranes for 60min at room temperature
with 5% (w/v) BSA (Sigma) in TBS with 0.05% Tween-20 (0.05% TBST). We
then stained the membranes overnight at 4C with 1:1,000 anti-acetyllysine
(#9441; Cell Signaling Technology), 1:1,000 anti-succinyllysine (PTM-401;
PTM BioLabs), 1:1,000 anti-malonyllysine (PTM-901; PTM BioLabs), or
1:1,000 anti-glutaryllysine (PTM-1151; PTM BioLabs) diluted in blocking
buffer. We then washed the membranes and incubated them for 60 min at
room temperature with the appropriate secondary antibody conjugated to
either IRDye 800CW or IRDye 680LT (LI-COR Biosciences) diluted 1:5,000 in
blocking buffer. We detected proteins and analyzed the band densities with
the Odyssey Infrared Imaging System (LI-COR Biosciences). We normalized
protein loading per lane with the Pierce BCA Protein Assay Kit (Thermo Fisher
Scientific) and used anti-COX IV (4D11-B3-E8) antibody (#11967; Cell
Signaling Technology) as the loading control.
SIRT3 and SIRT5 Activity Assays
We measured the SIRT3 activity and SIRT5 activity of mitochondrial isolates
from 661W cells with commercially available kits (Abcam and Enzo Life
Sciences, respectively) according to manufacturer’s instructions. We did not
add exogenous SIRT3/5 or NAD+ to the reaction mixture to allow us to accu-
rately quantify native deacylase activity.
Statistics
We performed statistical testing with GraphPad Prism (Version 6.0), using the
appropriate test for each dataset. Prior to all data analysis, we assessed the
normality of the data graphically and with the Kolmogorov-Smirnov test and,
when necessary, used appropriate non-parametric alternatives. We defined
statistical significance as a p value < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2016.08.073.
AUTHOR CONTRIBUTIONS
J.B.L. performed most of the experiments related to Figures 3H–3J, 4A–4C,
4E, 5, 6, and 7; S.K. performed most of the experiments related to Figures 1,
2, 3A–3G, and 4D. Conceptualization, R.S.A., S.I., and K.T.; Investigation,
J.B.L., S.K., N.B., M.Y., A. Santeford, A. Sene, R.N., N.Z., M.K., and J.Y.;
Writing – Original Draft, J.B.L. and S.K.; Writing – Review & Editing, J.B.L.,
R.S.A., S.I., and A. Sene; Supervision, R.S.A., S.I., and K.T.; Funding Acquisi-
tion, R.S.A., S.I., and K.T.
ACKNOWLEDGMENTS
ThisworkwassupportedbyNIHgrantsR01EY019287 (R.S.A.), AG024150 (S.I.),
AG037457 (S.I.), KL2TR000450 (J.Y.), P30DK56341 (J.Y.), P30DK020579 (J.Y.),DK104995 (J.Y.), and P30EY02687 (Vision Core Grant); the Carl Marshall
Reeves and Mildred Almen Reeves Foundation (R.S.A.); a Physician-Scientist
Award from Research to Prevent Blindness (R.S.A.); the Hope Center (R.S.A.
and S.I.), the Lacy Foundation (A. Sene and S.K.); the American Federation for
Aging Research (R.S.A.); the Schulak Family Gift Fund for Retinal Research
(R.S.A.); the Jeffrey Fort Innovation Fund (R.S.A.); Hope For Vision (R.S.A.);
the Robert Machemer Foundation (S.K.); and the Central Society for Clinical
and Translational Research (J.Y.). Additional funding comes from an unre-
stricted grant to the Department of Ophthalmology and Visual Sciences of
WashingtonUniversity School ofMedicine fromResearch to Prevent Blindness.
J.B.L. was supported by the Washington University in St. Louis Medical
Scientist Training Program (NIH grant T32GM007200), the Washington Univer-
sity in St. Louis Institute of Clinical and Translational Sciences (NIH grants
UL1TR000448, TL1TR000449), the Washington University Diabetic Cardiovas-
cular Disease Center, the American Federation for Aging Research, and the Vit-
reoRetinal Surgery Foundation. The authors acknowledge Douglas Cox for
technical assistance, Dr. David Beebe for advice regarding Seahorse experi-
ments, Dr. Kevin Yarasheski at the Washington University Metabolomics Core
for assistance with analyzing retinal samples, and Dr. Raul Mostoslavsky for
providing resources. R.S.A. is a co-founder of Metro Midwest Biotech, which
is developing NMN-based therapeutics.
Received: February 1, 2016
Revised: July 26, 2016
Accepted: August 19, 2016
Published: September 27, 2016
REFERENCES
Aı¨t-Ali, N., Fridlich, R., Millet-Puel, G., Cle´rin, E., Delalande, F., Jaillard, C.,
Blond, F., Perrocheau, L., Reichman, S., Byrne, L.C., et al. (2015). Rod-derived
cone viability factor promotes cone survival by stimulating aerobic glycolysis.
Cell 161, 817–832.
Alano, C.C., Garnier, P., Ying, W., Higashi, Y., Kauppinen, T.M., and Swanson,
R.A. (2010). NAD+ depletion is necessary and sufficient for poly(ADP-ribose)
polymerase-1-mediated neuronal death. J. Neurosci. 30, 2967–2978.
Ames, A., 3rd, Li, Y.Y., Heher, E.C., and Kimble, C.R. (1992). Energy meta-
bolism of rabbit retina as related to function: high cost of Na+ transport.
J. Neurosci. 12, 840–853.
Apte, R.S. (2010). Regulation of angiogenesis by macrophages. Adv. Exp.
Med. Biol. 664, 15–19.
Astuti, G.D., Bertelsen, M., Preising, M.N., Ajmal, M., Lorenz, B., Faradz, S.M.,
Qamar, R., Collin, R.W., Rosenberg, T., and Cremers, F.P. (2016). Comprehen-
sive genotyping reveals RPE65 as the most frequently mutated gene in Leber
congenital amaurosis in Denmark. Eur. J. Hum. Genet. 24, 1071–1079.
Bai, S., and Sheline, C.T. (2013). NAD(+) maintenance attenuates light induced
photoreceptor degeneration. Exp. Eye Res. 108, 76–83.
Brown, K.D., Maqsood, S., Huang, J.Y., Pan, Y., Harkcom, W., Li, W., Sauve,
A., Verdin, E., and Jaffrey, S.R. (2014). Activation of SIRT3 by the NAD+ precur-
sor nicotinamide riboside protects from noise-induced hearing loss. Cell
Metab. 20, 1059–1068.
Canto´, C., Houtkooper, R.H., Pirinen, E., Youn, D.Y., Oosterveer, M.H., Cen,
Y., Fernandez-Marcos, P.J., Yamamoto, H., Andreux, P.A., Cettour-Rose,
P., et al. (2012). The NAD(+) precursor nicotinamide riboside enhances oxida-
tive metabolism and protects against high-fat diet-induced obesity. Cell
Metab. 15, 838–847.
Chiang, P.W., Wang, J., Chen, Y., Fu, Q., Zhong, J., Chen, Y., Yi, X., Wu, R.,
Gan, H., Shi, Y., et al. (2012). Exome sequencing identifies NMNAT1mutations
as a cause of Leber congenital amaurosis. Nat. Genet. 44, 972–974.
Du, J., Zhou, Y., Su, X., Yu, J.J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J.H.,
Choi, B.H., et al. (2011). Sirt5 is a NAD-dependent protein lysine demalonylase
and desuccinylase. Science 334, 806–809.
Falk, M.J., Zhang, Q., Nakamaru-Ogiso, E., Kannabiran, C., Fonseca-Kelly, Z.,
Chakarova, C., Audo, I., Mackay, D.S., Zeitz, C., Borman, A.D., et al. (2012).Cell Reports 17, 69–85, September 27, 2016 83
NMNAT1 mutations cause Leber congenital amaurosis. Nat. Genet. 44, 1040–
1045.
Frezza, C., Cipolat, S., and Scorrano, L. (2007). Organelle isolation: functional
mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc.
2, 287–295.
Fu, Y., and Yau, K.W. (2007). Phototransduction in mouse rods and cones.
Pflugers Arch. 454, 805–819.
Garten, A., Petzold, S., Ko¨rner, A., Imai, S., and Kiess, W. (2009). Nampt: link-
ing NAD biology, metabolism and cancer. Trends Endocrinol. Metab. 20,
130–138.
Gerdts, J., Brace, E.J., Sasaki, Y., DiAntonio, A., and Milbrandt, J. (2015).
SARM1 activation triggers axon degeneration locally via NAD+ destruction.
Science 348, 453–457.
Grimm, C., and Reme´, C.E. (2013). Light damage as a model of retinal degen-
eration. Methods Mol. Biol. 935, 87–97.
Hartong, D.T., Berson, E.L., and Dryja, T.P. (2006). Retinitis pigmentosa. Lan-
cet 368, 1795–1809.
Hartong, D.T., Dange, M., McGee, T.L., Berson, E.L., Dryja, T.P., and Colman,
R.F. (2008). Insights from retinitis pigmentosa into the roles of isocitrate dehy-
drogenases in the Krebs cycle. Nat. Genet. 40, 1230–1234.
Hebert, A.S., Dittenhafer-Reed, K.E., Yu, W., Bailey, D.J., Selen, E.S.,
Boersma, M.D., Carson, J.J., Tonelli, M., Balloon, A.J., Higbee, A.J., et al.
(2013). Calorie restriction and SIRT3 trigger global reprogramming of the mito-
chondrial protein acetylome. Mol. Cell 49, 186–199.
Hennig, A.K., Peng, G.H., and Chen, S. (2013). Transcription coactivators p300
andCBP are necessary for photoreceptor-specific chromatin organization and
gene expression. PLoS ONE 8, e69721.
Hirschey, M.D., Shimazu, T., Jing, E., Grueter, C.A., Collins, A.M., Aouizerat,
B., Stanca´kova´, A., Goetzman, E., Lam, M.M., Schwer, B., et al. (2011).
SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the
development of the metabolic syndrome. Mol. Cell 44, 177–190.
Imai, S., and Guarente, L. (2014). NAD+ and sirtuins in aging and disease.
Trends Cell Biol. 24, 464–471.
Imai, S., and Yoshino, J. (2013). The importance of NAMPT/NAD/SIRT1 in the
systemic regulation of metabolism and ageing. Diabetes Obes. Metab. 15
(Suppl 3), 26–33.
Jaliffa, C., Ameqrane, I., Dansault, A., Leemput, J., Vieira, V., Lacassagne, E.,
Provost, A., Bigot, K., Masson, C., Menasche, M., and Abitbol, M. (2009). Sirt1
involvement in rd10 mouse retinal degeneration. Invest. Ophthalmol. Vis. Sci.
50, 3562–3572.
Kelly, J., Ali Khan, A., Yin, J., Ferguson, T.A., and Apte, R.S. (2007). Senes-
cence regulates macrophage activation and angiogenic fate at sites of tissue
injury in mice. J. Clin. Invest. 117, 3421–3426.
Klein, R., Peto, T., Bird, A., and Vannewkirk, M.R. (2004). The epidemiology of
age-related macular degeneration. Am. J. Ophthalmol. 137, 486–495.
Koenekoop, R.K., Wang, H., Majewski, J., Wang, X., Lopez, I., Ren, H., Chen,
Y., Li, Y., Fishman, G.A., Genead, M., et al.; Finding of Rare Disease Genes
(FORGE) Canada Consortium (2012). Mutations in NMNAT1 cause Leber
congenital amaurosis and identify a new disease pathway for retinal degener-
ation. Nat. Genet. 44, 1035–1039.
Kolesnikov, A.V., Fan, J., Crouch, R.K., and Kefalov, V.J. (2010). Age-related
deterioration of rod vision in mice. J. Neurosci. 30, 11222–11231.
Kolesnikov, A.V., Tang, P.H., Parker, R.O., Crouch, R.K., and Kefalov, V.J.
(2011). The mammalian cone visual cycle promotes rapid M/L-cone pigment
regeneration independently of the interphotoreceptor retinoid-binding protein.
J. Neurosci. 31, 7900–7909.
Kooragayala, K., Gotoh, N., Cogliati, T., Nellissery, J., Kaden, T.R., French, S.,
Balaban, R., Li, W., Covian, R., and Swaroop, A. (2015). Quantification of ox-
ygen consumption in retina ex vivo demonstrates limited reserve capacity of
photoreceptor mitochondria. Invest. Ophthalmol. Vis. Sci. 56, 8428–8436.
Laurent, G., German, N.J., Saha, A.K., de Boer, V.C., Davies, M., Koves, T.R.,
Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., et al. (2013). SIRT484 Cell Reports 17, 69–85, September 27, 2016coordinates the balance between lipid synthesis and catabolism by repressing
malonyl CoA decarboxylase. Mol. Cell 50, 686–698.
Le, Y.Z., Ash, J.D., Al-Ubaidi, M.R., Chen, Y., Ma, J.X., and Anderson, R.E.
(2004). Targeted expression of Cre recombinase to cone photoreceptors in
transgenic mice. Mol. Vis. 10, 1011–1018.
Li, S., Chen, D., Sauve´, Y., McCandless, J., Chen, Y.J., and Chen, C.K. (2005).
Rhodopsin-iCre transgenic mouse line for Cre-mediated rod-specific gene
targeting. Genesis 41, 73–80.
Lin, J.B., Tsubota, K., and Apte, R.S. (2016). A glimpse at the aging eye. npj
Aging Mechan. Dis. 2, 16003.
Lombard, D.B., Alt, F.W., Cheng, H.L., Bunkenborg, J., Streeper, R.S., Mosto-
slavsky, R., Kim, J., Yancopoulos, G., Valenzuela, D., Murphy, A., et al. (2007).
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetyla-
tion. Mol. Cell. Biol. 27, 8807–8814.
Mouchiroud, L., Houtkooper, R.H., Moullan, N., Katsyuba, E., Ryu, D., Canto´,
C., Mottis, A., Jo, Y.S., Viswanathan, M., Schoonjans, K., et al. (2013). The
NAD(+)/sirtuin pathway modulates longevity through activation of mitochon-
drial UPR and FOXO signaling. Cell 154, 430–441.
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., and Sassone-Corsi, P.
(2009). Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Sci-
ence 324, 654–657.
Nishida, Y., Rardin, M.J., Carrico, C., He, W., Sahu, A.K., Gut, P., Najjar, R.,
Fitch, M., Hellerstein, M., Gibson, B.W., and Verdin, E. (2015). SIRT5 regulates
both cytosolic and mitochondrial protein malonylation with glycolysis as a
major target. Mol. Cell 59, 321–332.
Okawa, H., Sampath, A.P., Laughlin, S.B., and Fain, G.L. (2008). ATP con-
sumption by mammalian rod photoreceptors in darkness and in light. Curr.
Biol. 18, 1917–1921.
Papanicolaou, K.N., O’Rourke, B., and Foster, D.B. (2014). Metabolism leaves
its mark on the powerhouse: recent progress in post-translational modifica-
tions of lysine in mitochondria. Front. Physiol. 5, 301.
Parihar, P., Solanki, I., Mansuri, M.L., and Parihar, M.S. (2015). Mitochondrial
sirtuins: emerging roles in metabolic regulations, energy homeostasis and
diseases. Exp. Gerontol. 61, 130–141.
Park, J., Chen, Y., Tishkoff, D.X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y.,
Zwaans, B.M., Skinner, M.E., et al. (2013). SIRT5-mediated lysine desucciny-
lation impacts diverse metabolic pathways. Mol. Cell 50, 919–930.
Perrault, I., Hanein, S., Zanlonghi, X., Serre, V., Nicouleau, M., Defoort-Del-
hemmes, S., Delphin, N., Fares-Taie, L., Gerber, S., Xerri, O., et al. (2012).
Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset
severe macular and optic atrophy. Nat. Genet. 44, 975–977.
Perron, N.R., Beeson, C., and Rohrer, B. (2013). Early alterations in mitochon-
drial reserve capacity; a means to predict subsequent photoreceptor cell
death. J. Bioenerg. Biomembr. 45, 101–109.
Ramsey, K.M., Mills, K.F., Satoh, A., and Imai, S. (2008). Age-associated loss
of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta
cell-specific Sirt1-overexpressing (BESTO) mice. Aging Cell 7, 78–88.
Ramsey, K.M., Yoshino, J., Brace, C.S., Abrassart, D., Kobayashi, Y., Mar-
cheva, B., Hong, H.K., Chong, J.L., Buhr, E.D., Lee, C., et al. (2009). Circadian
clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science
324, 651–654.
Rardin, M.J., He, W., Nishida, Y., Newman, J.C., Carrico, C., Danielson, S.R.,
Guo, A., Gut, P., Sahu, A.K., Li, B., et al. (2013a). SIRT5 regulates the mito-
chondrial lysine succinylome and metabolic networks. Cell Metab. 18,
920–933.
Rardin, M.J., Newman, J.C., Held, J.M., Cusack, M.P., Sorensen, D.J., Li, B.,
Schilling, B., Mooney, S.D., Kahn, C.R., Verdin, E., and Gibson, B.W. (2013b).
Label-free quantitative proteomics of the lysine acetylome in mitochondria
identifies substrates of SIRT3 in metabolic pathways. Proc. Natl. Acad. Sci.
USA 110, 6601–6606.
Rongvaux, A., Galli, M., Denanglaire, S., Van Gool, F., Dre`ze, P.L., Szpirer, C.,
Bureau, F., Andris, F., and Leo, O. (2008). Nicotinamide phosphoribosyl trans-
ferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte
development and cellular resistance to genotoxic stress. J. Immunol. 181,
4685–4695.
Samuels, I.S., Bell, B.A., Pereira, A., Saxon, J., and Peachey, N.S. (2015). Early
retinal pigment epithelium dysfunction is concomitant with hyperglycemia in
mousemodels of type 1 and type 2 diabetes. J. Neurophysiol. 113, 1085–1099.
Sasaki, Y., Margolin, Z., Borgo, B., Havranek, J.J., and Milbrandt, J. (2015).
Characterization of Leber congenital amaurosis-associated NMNAT1 mu-
tants. J. Biol. Chem. 290, 17228–17238.
Satoh, A., and Imai, S. (2014). Systemic regulation of mammalian ageing and
longevity by brain sirtuins. Nat. Commun. 5, 4211.
Schimel, A.M., Abraham, L., Cox, D., Sene, A., Kraus, C., Dace, D.S., Ercal, N.,
and Apte, R.S. (2011). N-acetylcysteine amide (NACA) prevents retinal degen-
eration by up-regulating reduced glutathione production and reversing lipid
peroxidation. Am. J. Pathol. 178, 2032–2043.
Schwer, B., Eckersdorff, M., Li, Y., Silva, J.C., Fermin, D., Kurtev, M.V., Gial-
lourakis, C., Comb, M.J., Alt, F.W., and Lombard, D.B. (2009). Calorie restric-
tion alters mitochondrial protein acetylation. Aging Cell 8, 604–606.
Sene, A., and Apte, R.S. (2014). Eyeballing cholesterol efflux and macrophage
function in disease pathogenesis. Trends Endocrinol. Metab. 25, 107–114.
Silberman, D.M., Ross, K., Sande, P.H., Kubota, S., Ramaswamy, S., Apte,
R.S., andMostoslavsky, R. (2014). SIRT6 is required for normal retinal function.
PLoS ONE 9, e98831.
Sol, E.M., Wagner, S.A., Weinert, B.T., Kumar, A., Kim, H.S., Deng, C.X., and
Choudhary, C. (2012). Proteomic investigations of lysine acetylation identify
diverse substrates of mitochondrial deacetylase sirt3. PLoS ONE 7, e50545.
Stein, L.R., and Imai, S. (2014). Specific ablation of Nampt in adult neural stem
cells recapitulates their functional defects during aging. EMBO J. 33, 1321–
1340.
Stein, L.R., Wozniak, D.F., Dearborn, J.T., Kubota, S., Apte, R.S., Izumi, Y.,
Zorumski, C.F., and Imai, S. (2014). Expression of Nampt in hippocampal
and cortical excitatory neurons is critical for cognitive function. J. Neurosci.
34, 5800–5815.
Still, A.J., Floyd, B.J., Hebert, A.S., Bingman, C.A., Carson, J.J., Gunderson,
D.R., Dolan, B.K., Grimsrud, P.A., Dittenhafer-Reed, K.E., Stapleton, D.S.,
et al. (2013). Quantification of mitochondrial acetylation dynamics highlights
prominent sites of metabolic regulation. J. Biol. Chem. 288, 26209–26219.
Tan, E., Ding, X.Q., Saadi, A., Agarwal, N., Naash, M.I., and Al-Ubaidi, M.R.
(2004). Expression of cone-photoreceptor-specific antigens in a cell line
derived from retinal tumors in transgenic mice. Invest. Ophthalmol. Vis. Sci.
45, 764–768.
Tan,M., Peng, C., Anderson, K.A., Chhoy, P., Xie, Z., Dai, L., Park, J., Chen, Y.,
Huang, H., Zhang, Y., et al. (2014). Lysine glutarylation is a protein posttrans-
lational modification regulated by SIRT5. Cell Metab. 19, 605–617.Umino, Y., Solessio, E., and Barlow, R.B. (2008). Speed, spatial, and temporal
tuning of rod and cone vision in mouse. J. Neurosci. 28, 189–198.
van Leeuwen, R., Klaver, C.C., Vingerling, J.R., Hofman, A., and de Jong, P.T.
(2003). Epidemiology of age-related maculopathy: a review. Eur. J. Epidemiol.
18, 845–854.
Wenzel, A., Reme, C.E., Williams, T.P., Hafezi, F., and Grimm, C. (2001). The
Rpe65 Leu450Met variation increases retinal resistance against light-induced
degeneration by slowing rhodopsin regeneration. J. Neurosci. 21, 53–58.
Wong, F., and Kwok, S.Y. (2016). The survival of cone photoreceptors in reti-
nitis pigmentosa. JAMA Ophthalmol. 134, 249–250.
Wright, A.F., Chakarova, C.F., Abd El-Aziz, M.M., and Bhattacharya, S.S.
(2010). Photoreceptor degeneration: genetic and mechanistic dissection of a
complex trait. Nat. Rev. Genet. 11, 273–284.
Xia, J., Sinelnikov, I.V., Han, B., and Wishart, D.S. (2015). MetaboAnalyst 3.0–
making metabolomics more meaningful. Nucleic Acids Res. 43, W251–W257.
Yang, H., Yang, T., Baur, J.A., Perez, E., Matsui, T., Carmona, J.J., Lamming,
D.W., Souza-Pinto, N.C., Bohr, V.A., Rosenzweig, A., et al. (2007). Nutrient-
sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095–1107.
Yau, K.W., and Hardie, R.C. (2009). Phototransduction motifs and variations.
Cell 139, 246–264.
Ying, W. (2006). NAD+ and NADH in cellular functions and cell death. Front.
Biosci. 11, 3129–3148.
Yoshino, J., and Imai, S. (2013). Accurate measurement of nicotinamide
adenine dinucleotide (NAD+) with high-performance liquid chromatography.
Methods Mol. Biol. 1077, 203–215.
Yoshino, J., Mills, K.F., Yoon, M.J., and Imai, S. (2011). Nicotinamide mononu-
cleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and
age-induced diabetes in mice. Cell Metab. 14, 528–536.
Yu, J., Sadhukhan, S., Noriega, L.G., Moullan, N., He, B., Weiss, R.S., Lin, H.,
Schoonjans, K., and Auwerx, J. (2013). Metabolic characterization of a Sirt5
deficient mouse model. Sci. Rep. 3, 2806.
Zhang, Y., Bharathi, S.S., Rardin, M.J., Uppala, R., Verdin, E., Gibson, B.W.,
and Goetzman, E.S. (2015). SIRT3 and SIRT5 regulate the enzyme activity
and cardiolipin binding of very long-chain acyl-CoA dehydrogenase. PLoS
ONE 10, e0122297.
Zhou, M., Ottenberg, G., Sferrazza, G.F., Hubbs, C., Fallahi, M., Rumbaugh,
G., Brantley, A.F., and Lasme´zas, C.I. (2015). Neuronal death induced by mis-
folded prion protein is due to NAD+ depletion and can be relieved in vitro and
in vivo by NAD+ replenishment. Brain 138, 992–1008.Cell Reports 17, 69–85, September 27, 2016 85
